Viveve Medical Past Earnings Performance

Past criteria checks 0/6

There is insufficient data on Viveve Medical's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Last Earnings Update30 Sep 2022

Recent past performance updates

Recent updates

Viveve to get US patent for technology to treat female stress urinary incontinence

Oct 04

Viveve Medical receives patent for dual-energy technology in Taiwan

Jul 12

Viveve under pressure after upsizes capital raise, prices offering at $3.40

Jan 14

Viveve regains compliance with Nasdaq

Dec 17

Viveve jumps 19% after FDA clearance for expansion of manufacturing treatment tips

Dec 03

Revenue & Expenses Breakdown
Beta

How Viveve Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:VIVE Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 227-28148
30 Jun 227-29139
31 Mar 227-271310
31 Dec 216-27139
30 Sep 217-25138
30 Jun 217-23136
31 Mar 216-26135
31 Dec 205-26145
30 Sep 205-35165
30 Jun 205-39186
31 Mar 205-40207
31 Dec 197-43238
30 Sep 1910-41299
30 Jun 1913-463311
31 Mar 1918-473712
31 Dec 1819-503913
30 Sep 1819-473713
30 Jun 1818-443514
31 Mar 1816-433313
31 Dec 1715-372912
30 Sep 1713-332411
30 Jun 1710-282010
31 Mar 179-23169
31 Dec 167-20138
30 Sep 165-18118
30 Jun 164-1697
31 Mar 163-1496
31 Dec 151-1285
30 Sep 151-1074
30 Jun 150-1073
31 Mar 150-852
31 Dec 140-641
30 Sep 140-541
30 Jun 140-431
31 Mar 140-431
31 Dec 130-431

Quality Earnings: Insufficient data to determine if VIVE has high quality earnings.

Growing Profit Margin: Insufficient data to determine if VIVE's profit margins have improved over the past year.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if VIVE's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare VIVE's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if VIVE's earnings growth over the past year exceeded the Medical Equipment industry average.


Return on Equity

High ROE: VIVE has a negative Return on Equity (0%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.